User-generated content is a very popular way to allow others to evangelize a brand, product or service, but it has generally been considered off-limits for the pharmaceutical industry because of the potential negatives of adverse event reporting. One way for pharmaceuticals to find out what people are saying about them has been to monitor the conversations within blogs and message boards (also known as forums). This allows the discovery of some of the information gaps that exist between users and the pharmaceutical websites that they visit.
Many patients, their family members, or concerned friends are going online not just to share their stories, but to seek information from others like them – those with a common condition and/or treatment. The answers they look for may include dosing and side effects, which are among the subjects that can easily lead to misinformation on the Internet. Monitoring their conversations can help guide future content development, helping to preemptively answer frequently asked questions. Incorporating this FAQ data with popular key phrases is another valuable way to inform users and help rankings within search engines.
Umbria, which bills itself as a “marketing intelligence company that mines the blogosphere and other public forums for real-time insights into companies, products, people, and issues,” provides reporting on prominent topics, and is an AA|RF partner. If a pharmaceutical company, or an organization in another highly-regulated industry, has wrestled with the idea of letting consumers write about them on their own sites, a thorough analysis of what is already out there may help to make that decision easier, and may lead to some hitherto undiscovered feedback from users.